Pharmabiz56m
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act
Govt yet to notify rules for compounding offences as per amendments introduced through Jan Vishwas Act: Shardul Nautiyal, Mumbai Wednesday, January 8, 2025, 08:00 Hrs [IST] Despit ...
Pharmabiz56m
Govt must adopt a pragmatic approach on revised Schedule M similar to US FDA compliance: Manoj Palrecha
Govt must adopt a pragmatic approach on revised Schedule M similar to US FDA compliance: Manoj Palrecha: Nandita Vijayasimha, Bengaluru Wednesday, January 8, 2025, 08:00 Hrs [IST] ...
Pharmabiz56m
TN DCA gearing up for inspection of pharma units to ensure compliance with revised Schedule M
Peethaambaran Kunnathoor, Chennai Wednesday, January 8, 2025, 08:00 Hrs [IST] ...
Pharmabiz56m
CDSCO seeks industry comment on updated classification list of four medical devices categories
CDSCO seeks industry comment on updated classification list of four medical devices categories: Gireesh Babu, New Delhi Wednesday, January 8, 2025, 08:00 Hrs [IST] The Central Dru ...
Pharmabiz56m
MAKE HOSPITALS A SAFER PLACE
Of course, safety and security in hospitals have been a matter of great concern in the country. There have been reports of intermittent violence against the medical fraternity by the relatives of the ...
Pharmabiz56m
Indian health sector navigating complexities of M&As: Harsh Vaish
Harsh Vaish: Nandita Vijayasimha, Bengaluru Wednesday, January 8, 2025, 08:00 Hrs [IST] Mergers and Acquisitions (M&As) have ...
Pharmabiz14h
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...
Pharmabiz15h
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary: Our Bureau, Mumbai Tuesday, January 7, 2025, 17:15 Hrs [IST] Zydus L ...
Pharmabiz16h
SunAct Cancer Institute ties up with Singapore’s CytoMed for phase 2 clinical trials on innovative Gamma Delta T-cell cancer therapy in India
Our Bureau, Mumbai Tuesday, January 7, 2025, 16:45 Hrs [IST] ...
Pharmabiz16h
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease: Aarhus, Denmark Tuesday, January 7, 2025, 16:00 Hrs [IST] NMD Ph ...
Pharmabiz18h
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints
Oculis Holding’s OCS-05 phase 2 ACUITY trial in acute optic neuritis meets primary safety endpoint and key secondary efficacy endpoints: Zug, Switzerland Tuesday, January 7, 202 ...
Pharmabiz15h
JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease
JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease: Hyogo, Japan Tuesday, January 7, 20 ...